SILO PHARMA, INC. Cash
SILO PHARMA, INC. (SILO) had Cash of $3 as of 2025-12-31, per its POS AM filed 2026-04-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-04-14
- 2025-12-31: Cash $3.00.
- 2025-09-30: Cash $3.00.
- 2025-06-30: Cash $3.00.
- 2025-03-31: Cash $3.00.
| Period end | Cash |
|---|---|
| 2025-12-31 | $3.00 POS AM · filed 2026-04-14 |
| 2025-09-30 | $3.00 10-Q · filed 2025-11-13 |
| 2025-06-30 | $3.00 10-Q · filed 2025-08-13 |
| 2025-03-31 | $3.00 10-Q · filed 2025-05-09 |
| 2024-06-30 | $3.00 10-Q · filed 2024-08-13 |
| 2024-06-04 | $3.00 10-Q · filed 2025-05-09 |
| 2023-09-30 | $330.82K 10-Q · filed 2023-11-13 |
| 2023-08-31 | $100.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $430.82K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $430.82K 10-Q · filed 2023-05-12 |
| 2022-10-13 | $430.82K 10-Q · filed 2023-11-13 |
| 2013-09-30 | $1.26M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $368.68K 10-Q · filed 2013-08-08 |
| 2013-03-31 | $10.10K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $279.00 10-Q · filed 2013-11-14 |
| 2012-09-30 | $279.00 10-Q · filed 2012-11-13 |
| 2012-06-30 | $813.00 10-Q · filed 2012-08-01 |
| 2012-03-31 | $3.71K 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.75K 10-K · filed 2013-03-05 |
| 2011-09-30 | $4.58K 10-Q · filed 2011-11-10 |
| 2011-06-30 | $25.80K 10-Q · filed 2011-08-15 |
| 2010-12-31 | $47.48K 10-K · filed 2012-01-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |